Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shingo Takada

Showing results (171-180 of 183) with videos related to

Pageof 19
Sort By:
Scientific Reports|March 7, 2019
Impaired mitochondrial oxidative phosphorylation capacity in epicardial adipose tissue is associated with decreased concentration of adiponectin and severity of coronary atherosclerosisTakayuki Nakajima, Takashi Yokota, Yasushige Shingu, et al.
Communications Biology|January 30, 2021
Cardiac-specific loss of mitoNEET expression is linked with age-related heart failureTakaaki Furihata, Shingo Takada, Naoya Kakutani, et al.
Circulation|October 30, 2018
Brain-Derived Neurotrophic Factor Improves Limited Exercise Capacity in Mice With Heart FailureJunichi Matsumoto, Shingo Takada, Shintaro Kinugawa, et al.
Anticancer Research|January 31, 2025
Efficacy of Second-line Nivolumab <i>Versus</i> Tyrosine Kinase Inhibitors for Renal Cell Carcinoma With Bone MetastasesGaku Yamamichi, Taigo Kato, Akihiro Yoshimura, et al.
Iscience|July 5, 2022
Protective roles of MITOL against myocardial senescence and ischemic injury partly via Drp1 regulationTakeshi Tokuyama, Hideki Uosaki, Ayumu Sugiura, et al.
Cancer Science|March 20, 2019
Diagnostic potential of TERT promoter and FGFR3 mutations in urinary cell-free DNA in upper tract urothelial carcinomaYujiro Hayashi, Kazutoshi Fujita, Kyosuke Matsuzaki, et al.
Japanese Journal of Clinical Oncology|February 2, 2024
Determination of enzalutamide long-term safety and efficacy for castration-resistant prostate cancer patients after combined anti-androgen blockade followed by alternative anti-androgen therapy: a multicenter prospective DELC studyAkira Nagahara, Motohide Uemura, Mototaka Sato, et al.
International Journal of Clinical Oncology|July 13, 2022
Real-world efficacy and safety of nivolumab plus ipilimumab in untreated metastatic renal cell carcinoma, and the impact of previous nephrectomy on clinical outcome: Japanese multi-institutional retrospective studyTaigo Kato, Kazutoshi Fujita, Takafumi Minami, et al.
Cardiovascular Research|May 14, 2020
Inhibition of xanthine oxidase in the acute phase of myocardial infarction prevents skeletal muscle abnormalities and exercise intoleranceHideo Nambu, Shingo Takada, Satoshi Maekawa, et al.
British Journal of Cancer|July 6, 2022
EphA2 on urinary extracellular vesicles as a novel biomarker for bladder cancer diagnosis and its effect on the invasiveness of bladder cancerEisuke Tomiyama, Kazutoshi Fujita, Kyosuke Matsuzaki, et al.
Pageof 19

Showing results (171-180 of 183) with videos related to

Sort By:
Pageof 19
Scientific Reports|March 7, 2019
Impaired mitochondrial oxidative phosphorylation capacity in epicardial adipose tissue is associated with decreased concentration of adiponectin and severity of coronary atherosclerosisTakayuki Nakajima, Takashi Yokota, Yasushige Shingu, et al.
Communications Biology|January 30, 2021
Cardiac-specific loss of mitoNEET expression is linked with age-related heart failureTakaaki Furihata, Shingo Takada, Naoya Kakutani, et al.
Circulation|October 30, 2018
Brain-Derived Neurotrophic Factor Improves Limited Exercise Capacity in Mice With Heart FailureJunichi Matsumoto, Shingo Takada, Shintaro Kinugawa, et al.
Anticancer Research|January 31, 2025
Efficacy of Second-line Nivolumab <i>Versus</i> Tyrosine Kinase Inhibitors for Renal Cell Carcinoma With Bone MetastasesGaku Yamamichi, Taigo Kato, Akihiro Yoshimura, et al.
Iscience|July 5, 2022
Protective roles of MITOL against myocardial senescence and ischemic injury partly via Drp1 regulationTakeshi Tokuyama, Hideki Uosaki, Ayumu Sugiura, et al.
Cancer Science|March 20, 2019
Diagnostic potential of TERT promoter and FGFR3 mutations in urinary cell-free DNA in upper tract urothelial carcinomaYujiro Hayashi, Kazutoshi Fujita, Kyosuke Matsuzaki, et al.
Japanese Journal of Clinical Oncology|February 2, 2024
Determination of enzalutamide long-term safety and efficacy for castration-resistant prostate cancer patients after combined anti-androgen blockade followed by alternative anti-androgen therapy: a multicenter prospective DELC studyAkira Nagahara, Motohide Uemura, Mototaka Sato, et al.
International Journal of Clinical Oncology|July 13, 2022
Real-world efficacy and safety of nivolumab plus ipilimumab in untreated metastatic renal cell carcinoma, and the impact of previous nephrectomy on clinical outcome: Japanese multi-institutional retrospective studyTaigo Kato, Kazutoshi Fujita, Takafumi Minami, et al.
Cardiovascular Research|May 14, 2020
Inhibition of xanthine oxidase in the acute phase of myocardial infarction prevents skeletal muscle abnormalities and exercise intoleranceHideo Nambu, Shingo Takada, Satoshi Maekawa, et al.
British Journal of Cancer|July 6, 2022
EphA2 on urinary extracellular vesicles as a novel biomarker for bladder cancer diagnosis and its effect on the invasiveness of bladder cancerEisuke Tomiyama, Kazutoshi Fujita, Kyosuke Matsuzaki, et al.
Pageof 19